Scrip Regulatory Affairs
The New EU Data Protection Regulation: What will the Impact be on the Life Sciences Industry?
March 2012
The EU Data Protection Regulation proposed by the European Commission in January will - if adopted in its current form - require pharmaceutical and medical device companies to adopt a new approach to data processing and data protection.
This article was published in the March 2012 issue of Scrip Regulatory Affairs.
Contacts
Capabilities
Suggested News & Insights
Sidley Represents MarineMax in Its US$1.5 Billion Sale to Blackstone Infrastructure Portfolio Company, Safe HarborAugust 10, 2026South Carolina Takes a Hard Line on Age-Appropriate Design – Audits, Parental Controls, Employee Personal Liability, and MoreJuly 31, 2026EDPB Publishes Draft Guidelines on AnonymisationJuly 27, 2026What Do the European Data Protection Board’s Web Scraping Guidelines Mean for AI Training Datasets?July 23, 2026White House Issues Executive Orders on Quantum Innovation and SecurityJuly 1, 2026EU AI Act Transparency Obligations: Preparing for Compliance by 2 August 2026June 24, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory